ANGIOSCULPT PTA SCORING BALLOON CATHETER

K082059 · Angioscore, Inc. · PNO · Aug 11, 2008 · Cardiovascular

Device Facts

• Record ID: K082059
• Device Name: ANGIOSCULPT PTA SCORING BALLOON CATHETER
• Applicant: Angioscore, Inc.
• Product Code: PNO · Cardiovascular
• Decision Date: Aug 11, 2008
• Decision: SESE
• Submission Type: Special
• Regulation: 21 CFR 870.1250
• Device Class: Class 2
• Attributes: Therapeutic

Intended Use

The AngioSculpt PTA Scoring Balloon Catheter is intended for dilatation of lesions in the iliac, femoral, ilio-femoral, popliteal, and infra popliteal arteries, and for the treatment of obstructive lesions of native or synthetic arteriovenous dialysis fistulae. Not for use in the coronary or neuro-vasculature.

Device Story

AngioSculpt PTA Scoring Balloon Catheter is a two-lumen catheter featuring a nylon-blend balloon with an integrated nitinol scoring element. Used by physicians in clinical settings for peripheral artery angioplasty and dialysis fistula treatment. The nitinol element wraps around the balloon to create focal concentrations of dilating force during inflation; this mechanism minimizes balloon slippage and assists in luminal expansion of stenotic vessels. Radiopaque markers on the balloon facilitate precise positioning under fluoroscopy. The device provides a controlled, expandable segment at specific pressures to treat obstructive lesions. Benefits include improved procedural control and effective vessel dilation compared to standard angioplasty balloons.

Clinical Evidence

No clinical data provided; substantial equivalence is supported by design verification and validation testing.

Technological Characteristics

Two-lumen catheter; nylon-blend balloon; nitinol scoring element; radiopaque markers for positioning. Operates via mechanical balloon inflation to provide focal dilating force. Sterilization method not specified.

Indications for Use

Indicated for patients requiring dilatation of lesions in iliac, femoral, ilio-femoral, popliteal, and infra popliteal arteries, and treatment of obstructive lesions in native or synthetic arteriovenous dialysis fistulae. Contraindicated for coronary or neuro-vasculature use.

Regulatory Classification

Identification

A percutaneous catheter is a device that is introduced into a vein or artery through the skin using a dilator and a sheath (introducer) or guide wire.

Predicate Devices

• AngioSculpt® Scoring Balloon Catheter (K072225)
• AngioSculpt® Scoring Balloon Catheter (K080151)

Submission Summary (Full Text)

{0}------------------------------------------------

Image /page/0/Picture/1 description: The image is a black and white logo for the Department of Health & Human Services - USA. The logo consists of a circle with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the top half of the circle. Inside the circle is a symbol that resembles a stylized caduceus, which is a symbol often associated with healthcare. The symbol has a staff with a snake winding around it.

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002

May 31, 2016

AngioScore Inc. c/o. Kimberley Kline Principal Regulatory Affairs Specialist 5055 Brandin Court Fremont, CA 94538

Re: K082059

Trade/Device Name: AngioSculpt® PTA Scoring Balloon Catheter Regulation Number: 21 CFR 870.1250 Regulation Name: Percutaneous catheter Regulatory Class: Class II (two) Product Code: PNO Dated: July 18, 2008 Received: July 21, 2008

Dear Ms. Kline:

This letter corrects our substantially equivalent letter of August 11, 2008.

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must

{1}------------------------------------------------

Page 2 - Ms. Kimberley Kline

comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number [phone] or [phone] or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number [phone] or [phone] or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely yours,

# Misti L. Malone -S

for Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

Image /page/2/Picture/0 description: The image shows the logo for AngioScore. The logo consists of a stylized letter "A" inside a square on the left, followed by the word "AngioScore" in a sans-serif font. There is a small circle above and to the right of the "e" in "AngioScore", which is a registered trademark symbol.

## INDICATIONS FOR USE STATEMENT

510(k) Number (if known): ____________________________________________________________________________________________________________________________________________________

Device Name: AngioSculpt® Scoring Balloon Catheter

Indications for Use:

The AngioSculpt PTA Scoring Balloon Catheter is intended for dilatation of lesions in the iliac, femoral, ilio-femoral, popliteal, and infra popliteal arteries, and for the treatment of obstructive lesions of native or synthetic arteriovenous dialysis fistulae. Not for use in the coronary or neuro-vasculature.

Prescription Use x (Part 21 CFR 801 Subpart D)

:

、.

AND/OR

Over-The-Counter Use (21 CFR 801 Subpart C)

## (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

| (Division Sign-Off) |
|------------------------------------|
| Division of Cardiovascular Devices |

| Page | 1 of 1 |
|---------------|---------|
| 510(k) Number | k082059 |

:

5055 Brandin Court Fremont CA 94538 www.angioscore.com Toll Free: 1.877.264.4692 Phone: [phone] Fal: 999.33.99

{3}------------------------------------------------

Image /page/3/Picture/1 description: The image contains the logo for AngioScore. The logo consists of a stylized letter "A" inside a square on the left, followed by the word "AngioScore" in a simple, sans-serif font. A small trademark symbol is present to the upper right of the word "AngioScore".

AUG 1 1 رنالك 1

# 510(k) Summary for the AngioSculpt Scoring Ballovn Catheter

### 1. Submitter's Name / Contact Person

Submitter:

AngioScore, Inc. 5055 Brandin Court Fremont, CA 94538

Contact Person:

Kimberley Kline Principal Regulatory Specialist Phone: [phone] Fax: [phone]

Summary Preparation Date: July 18, 2008

#### 2. General Information

| Trade Name: | AngioSculpt® PTA Scoring Balloon Cathete |
|----------------------|----------------------------------------------------------------|
| Common / Usual Name: | Angioplasty catheter |
| Classification Name: | Percutaneous catheter |
| Product Codes: | DQY and LIT |
| Predicate Devices: | AngioSculpt® Scoring Balloon Catheter<br>(K072225 and K080151) |

### 3. Intended Use / Indications

The AngioSculpt PTA Scoring Balloon Catheter is intended for dilatation of lesions in the iliac, femoral, ilio-femoral, popliteal, and infra popliteal arteries, and for the treatment of obstructive lesions of native or synthetic arteriovenous dialysis fistulae, Not for use in the coronary or neuro-vasculature.

### 4. Device Description

The AngioSculpt catheter is a standard two-lumen catheter with a scoring balloon near the distal tip. The distal end of the catheter has a conventional nylon-blend balloon with a nitinol scoring element that wraps around the balloon. The scoring element creates focal concentrations of dilating force which minimizes balloon. slippage and assists with luminal expansion of stenotic arteries. The balloon has radiopaque markers to aid in positioning the balloon in the stennsis, and is designed to provide an expandable segment of known diameter and length at a specific pressure.

5055 Brandin Count Fremont CA 94538 www.angioscore.com Toll Free: 1.877.264.4692 Phone: [phone] FRS

{4}------------------------------------------------

#### 5. Substantial Equivalence Comparison

The AngioSculpt catheter shares the same indications for use, fundamental design, scientific technology (onerating principle), functional performance, and materials as the currently marketed AngioSculpt catheter. Design verification and validation testing demonstrated adequate device performance and confirmed that no new questions of safety or effectiveness for peripheral balloon angioplasty devices were raised. The changes to the subject AngioSculpt PTA Scoring Balloon Catheter do not affect the intended use of the device, alter the fundamental scientific technology of the device, or raise new issues of safety and effectiveness. The AngioSculpt PTA Scoring Balloon Catheter is therefore, substantially equivalent to the predicate AngioSculpt catheters.